Salem Partners, LLC - Investment Banking and Wealth Management
  • Home
  • About
  • Investment Banking
    • Valuation Services
    • Media & Entertainment
    • Healthcare & Life Sciences
    • Real Estate
    • Specialty & Lender Finance
    • Transactions
  • Wealth Management
    • Portfolio Log In
  • Real Estate Development
  • Professionals
  • News
  • Contact

OncoNano Announces Positive Preclinical Data for ONM-501 at AACR 2022 Annual Meeting

4/13/2022

 
Picture
OncoNano Medicine, Inc. today announced positive results from a preclinical study of ONM-501, a novel dual-activating polyvalent STING (STimulator of INterferon Genes) agonist for immuno-oncology applications. The data, presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, demonstrate the efficacy and tolerability of ONM-501 in animal models for multiple tumor types. ONM-501 is formulated with the core OncoNano OMNITM polymer technology consisting of STING-activating pH-sensitive micelles loaded with an endogenous agonist...(read more). 

OncoNano Announces Positive Preclinical Data for Tumor Specific Delivery with the ON-BOARD Platform at AACR 2022 Annual Meeting

4/12/2022

 
Picture
OncoNano Medicine, Inc. today announced positive results from the company’s ON-BOARD™ pH-sensitive nanoparticle platform. The data, presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, demonstrate that the clinically validated ON-BOARD™ platform has the potential to be a universal tool for tumor-specific activation and the efficient delivery of proteins for an improved therapeutic index.

“Our ON-BOARD micelle platform is designed to efficiently carry a broad range of payloads to the tumor microenvironment. Capable of being tuned to deliver either small molecules or biologics, the ON-BOARD platform has the potential to be a universal tool for targeted delivery of therapeutics to a range of cancers,” said Tian Zhao, Ph.D., Vice President of Research & Development for OncoNano Medicine, Inc...(read more). 

Salem Partners Announces Successful Closing of a $50 Million Programmatic Equity Joint Venture

11/19/2021

 
Picture
Salem Partners, LLC (“Salem”) is pleased to announce a successful closing of a $50 million programmatic equity joint venture on November 19th, 2021. The joint venture was structured between Salem’s client, Guardian Yards (“Guardian” or the “Company”) and a West Coast / Los Angeles based private equity firm focused on opportunistic commercial real estate investing. The goal of the joint venture will be to acquire land sites to develop high-performing Industrial Outdoor Storage (“IOS”) | Industrial Service Facilities (“ISF”) real estate properties across the major California markets....(read more)​

Hubbell Incorporated Acquires Armorcast Products Company

2/2/2021

 
Picture
​Hubbell Incorporated, (NYSE: HUBB) $8.62B, manufacturer of electronic, industrial, and utility products to solve business challenges, has acquired Armorcast Products Company (“Armorcast”). In coming together, Armorcast’s strong customer base and diverse product line helps Hubbell’s west coast expansion and entry into new market opportunities.
​
Salem Partners has enjoyed a long-standing relationship with the Boghossian family, 2nd generation owners of Armorcast...(read more)

Salem announces successful completion of programmatic joint-venture in real estate / Multifamily sector

2/28/2017

 
Picture
LOS ANGELES, CA -- ​Salem Partners is pleased to announce the successful completion of a programmatic joint-venture in the real estate / multifamily sector for its client, Grand Peaks Properties, Inc. (“GPP”). The joint-venture is between GPP and a global family office with the objective to aggregate $1 billion of multifamily assets.  GPP is a vertically-integrated, national operator... (read more)

Honolulu City Council Approves Salem Partners’ Plan for $700 Million, 36-Story MixeD-use tower

10/11/2016

 
Picture
​LOS ANGELES, CA - The Honolulu City Council has approved a $700 million, 36-story mixed-use tower across from the Convention Center to be developed by Los Angeles-based Salem Partners. Located at the intersection of Kapiolani Boulevard and Atkinson Drive, Mana`olana Place is the first approved project in the city’s newly adopted Ala Moana transit-oriented district and is expected to be a catalyst for further investment in the area. The iconic tower’s 505,000 square feet will house a 125-room ultra-luxury hotel.... (read more)

Architects Hawaii Garners Top Design Award in National Competition

12/15/2015

 
Picture
HONOLULU, HI - ​Walgreens’ Hawaii flagship store in Honolulu won this year’s highest level of recognition in the retail store design category of the International Council of Shopping Centers’ awards competition for U.S. design and development... (read more)

Femasys Announces Todd Creech as Chief Financial Officer

12/14/2015

 
Picture
ATLANTA, GA - December 14, 2015 --- Femasys Inc., a developer of innovative medical devices for the women’s healthcare market today announced the appointment of Todd A. Creech as Chief Financial Officer. Mr. Creech will serve as Femasys’ principal financial and... (read more)

WALGREENS SELLS ITS FLAGSHIP HAWAII STORE AND ADJACENT HEALD COLLEGE BUILDING FOR $73.5M

11/30/2015

 
Picture
HONOLULU, HI - Walgreens has sold its flagship Hawaii store across from Ala Moana Center in Honolulu, along with the adjacent Heald College Building on Kapiolani Boulevard, to Los Angeles-based investment bank and wealth management firm Salem Partners for a total of $73.5 million...(read more)

Local Investors Back Pryer Aerospace

10/7/2015

 
Picture
​TULSA, OK – Pryer Aerospace (“Pryer”), a manufacturer of aerospace components and assemblies with facilities in Tulsa and Claremore, OK, today announced today that Tulsa Capital Partners (“TCP”)... (read more)

Neos Therapeutics Announces Pricing of Initial Public Offering

7/23/2015

 
Picture
Dallas/Fort Worth, TX (July 23, 2015) — Neos Therapeutics, Inc. (“Neos” or “the Company”) today announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock at the initial public offering... (read more)

Femasys Secures Term Loan Facility from Silicon Valley Bank 

7/9/2015

 
Picture
ATLANTA, July 9, 2015 /PRNewswire/ -- Femasys Inc., a developer of innovative medical devices for the women's healthcare market, announced today that it has secured a term loan facility from Silicon Valley Bank.  Under the loan facility, the company ... (read more)


Neos Therapeutics files for an IPO with $69 million value

6/23/2015

 
Picture
After bringing in one of the top venture capital investments during first quarter 2015, Neos Therapeutics has filed for an initial public offering.  The Grand Prairie-based company, which develops medication for Attention Deficit/Hyperactivity Disorder, filed Friday to trade on the Nasdaq under ticker symbol NEOS. It has a place holder value... (read more)


Cynvenio Biosystems Announces $25.5 Million Series B Financing

6/17/2015

 
Picture
LOS ANGELES--(BUSINESS WIRE)--Cynvenio Biosystems, Inc., the pioneer in LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies, announced today the completion... (read more)

Robert Redford's Sundance Cinemas looks for a buyer

6/10/2015

 
Picture
LOS ANGELES, Calif., June 10, 2015 (LA TIMES) -- Robert Redford's Sundance Cinemas is putting itself up for sale.  Sundance Cinemas said in a statement that it has hired the investment bank Salem Partners to find a buyer for the small L.A.-based theater chain.  Sundance Cinemas is part of several entities overseen by Redford... (read more)


ZS Pharma Submits New Drug Application to U.S. Food and Drug Administration for ZS-9 for the Treatment of Hyperkalemia

5/26/2015

 
Picture
REDWOOD CITY, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic disorders, today announced that it has submitted a New Drug Application (NDA) to... (read more)

Femasys Completes $10.2 Million Series B Financing Round

4/29/2015

 
Picture
Atlanta, GA -April 29, 2015 - Femasys Inc., a developer of innovative medical devices for the women's healthcare market has raised a $10.2 million financing round. The investor group was led by Legacy Capital Partners and Mario Family Partners, the family offices of... (read more)

Salem Partners Advises PAVe (ProPark & Parkit Enterprises) in $500 million Parking Acquisitions Joint-Venture

4/22/2015

 
Picture
LOS ANGELES, CA, April 22, 2015 -- Salem Partners is pleased to announce the completion of a $500 million programmatic joint-venture in the real estate / parking sector for its client, Parking Acquisition Venture (PAVe). PAVe is a partnership between Propark America and Parkit and... (read more)

Salem Partners Advises Process Fab Inc. in Sale to Burtek Enterprises

12/10/2014

 
Picture
CHESTERFIELD, Mich., Dec. 10, 2014 /PRNewswire/ -- The Burtek Group ("Burtek") has acquired Process Fab, Inc. ("PFI") based inSanta Fe Springs, CA. The combination of Votaw Precision Technologies, Inc. ("Votaw") and PFI under the Burtek portfolio, brings together two of the best spaceflight and aerospace suppliers in the industry and creates a... (read more)

Salem Partners Advises Merlin RAMCo in Sale to Trive Capital

10/15/2014

 
Picture
DALLAS, Texas, JACKSONVILLE, Florida, and SAVANNAH, Tennessee, October 15, 2014 - Trive Capital ("Trive"), the Dallas-based private equity firm, is proud to announce its investments in Merlin RAMCo, LLC ("Merlin") and ISR Group LLC ("ISR"). Headquartered in Jacksonville, Florida, Merlin is a leading... (read more)

Salem Partners Advises Impresa Aerospace in Sale to Twin Haven Capital

10/7/2014

 
Picture
Gardena, CA (October 7, 2014) Impresa Aerospace, a leading supplier to the commercial and military aerospace industries, announced today that it has been acquired by a private equity fund managed by Twin Haven... (read more)

Millennium Entertainment Brass To Acquire Company's Distribution & Catalog Biz

8/19/2014

 
Picture
Millennium Entertainment, the distribution arm of Avi Lerner's Nu Image, officially went up for sale back in April 2013. Now there is a deal from within after entities like Luc Besson's EuropaCorp kicked the tires: The Millennium Entertainment management team led by CEO Bill Lee and private investment firm Virgo Investment Group are... (read more)

Salem Partners Advises Dynamic Paint Solutions in Sale to Valence Surface Technologies

8/14/2014

 
Picture
Private equity-backed Valence Technologies has acquired Pride Plating, Dynamic Paint Solutions and Coastline Metal Finishing.  Pride, headquartered in Tulsa, Oklahoma, provides processing and sub-assembly for large aluminum and titanium structures, specifically for aircrafts... (read more)


Former Cantor Real Estate I-Banker Targeting Private Capital at Salem Partners

8/12/2014

 
Picture
Salem Partners LLC, a boutique investment bank and wealth management firm, announced the addition of real estate veterans Jeff Barcy and Sean Lenz to its team in April. The pair hailed from Cantor Fitzgerald & Co., where Barcy ran the national real estate investment banking practice. Barcy recently spoke with SNL about his new position and his plans to focus on raising private... (read more)

ZS Pharma Announces Allowance of Two U.S. Patent Applications for ZS-9

7/8/2014

 
Picture
COPPELL, Texas, July 8, 2014 (GLOBE NEWSWIRE) -- ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, announced today that it has received Notices of Allowance from the U.S. Patent and Trademark...(read more) 

<<Previous

    News

    All
    Aerospace & Defense
    Healthcare & Life Sciences
    Investment Banking
    Media & Entertainment
    Real Estate
    Specialty & Lender Finance
    Wealth Management

    Archives

    April 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    February 2021
    December 2020
    August 2020
    November 2019
    August 2019
    July 2019
    December 2018
    November 2018
    September 2018
    July 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    July 2017
    February 2017
    December 2016
    November 2016
    October 2016
    July 2016
    December 2015
    November 2015
    October 2015
    July 2015
    June 2015
    May 2015
    April 2015
    December 2014
    October 2014
    August 2014
    July 2014
    June 2014
    April 2014
    March 2014
    November 2013
    October 2013
    February 2013
    December 2012
    October 2012
    February 2012
    January 2012
    December 2011
    September 2011
    August 2011
    June 2011
    January 2010
    December 2009
    November 2009
    August 2009
    June 2009
    February 2009
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    February 2008
    December 2007
    July 2007
    May 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006

    RSS Feed

© 2016 by Salem Partners LLC - All Rights Reserved. Member FINRA/SIPC.
11111 Santa Monica Blvd. Suite 2250, Los Angeles, CA 90025